Hercules Capital, Inc. (HTGC) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reflects a stable financial performance with efficient debt management and strong credit quality. The Q&A reveals a disciplined approach to underwriting and capital deployment, with optimism for 2026 opportunities. The company maintains a diversified portfolio and strategic M&A success, despite market volatility. The deprioritization of PIK and focus on cash income indicate prudent financial management. Overall, the positive outlook for 2026 and robust commitments support a positive stock price reaction.
Key Financial Performance
Total New Debt and Equity Commitments $1.81 billion in Q1 2026, a record high. This represents strong business momentum and disciplined capital deployment.
Gross Fundings Over $706 million in Q1 2026, contributing to $298 million of net debt investment portfolio growth.
Total Investment Income $141.5 million in Q1 2026, a record high, up 18.4% year-over-year. Growth driven by increased debt portfolio.
Net Investment Income $88.1 million or $0.48 per share in Q1 2026, up 13.8% year-over-year. Growth supported by strong portfolio performance.
Return on Equity (ROE) 16.9% in Q1 2026, reflecting strong profitability and efficient capital utilization.
GAAP Effective Yield 12.8% in Q1 2026, consistent with guidance, reflecting stable portfolio performance.
Core Yield 12.2% in Q1 2026, consistent with guidance, reflecting stable portfolio performance.
GAAP Leverage 115.4% in Q1 2026, up from 104.4% in Q4 2025, reflecting increased leverage to support growth.
Liquidity $454.5 million in BDC and over $1 billion across the platform in Q1 2026, ensuring strong financial flexibility.
Net Asset Value (NAV) Per Share $11.90 in Q1 2026, a decrease of 1.9% from Q4 2025, primarily due to unrealized depreciation from market yield adjustments.
Unrealized Depreciation on Debt Investments $31.1 million in Q1 2026, largely due to market yield adjustments and valuation movements.
Unrealized Depreciation on Equity Positions $12.3 million in Q1 2026, largely due to market volatility.
PIK Income 9.1% of total revenue in Q1 2026, down from 10.5% in 2025, reflecting reduced reliance on PIK income.
Weighted Average Cost of Debt 5.1% in Q1 2026, stable compared to Q4 2025, reflecting efficient debt management.
Portfolio Credit Quality Weighted average internal credit rating of 2.11 in Q1 2026, stable compared to Q4 2025, reflecting strong credit performance.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Record Originations: Achieved all-time record originations of over $1.81 billion in Q1 2026, consistent with prior guidance.
Investment Portfolio Growth: Net debt investment portfolio grew by $298 million in Q1 2026.
Investment Income: Generated record total investment income of $141.5 million in Q1 2026.
Asset Management Growth: Hercules Capital is now managing approximately $6.1 billion of assets, a 21.8% increase from a year ago.
Life Sciences and Technology Focus: Approximately 56% of commitments and 60% of fundings were to life sciences companies, while 44% of commitments were to tech companies in Q1 2026.
M&A and IPO Activity: Four new M&A events and two IPO filings occurred in Q1 2026, with one IPO completed in April.
Liquidity Position: Ended Q1 2026 with over $1 billion of liquidity across the platform.
Credit Quality: Maintained strong credit quality with 70.5% of credits rated Grade 1 and 2, and only 0.9% rated as distressed (Grades 4 and 5).
Leverage Management: GAAP leverage increased to 115.4%, within the historical range, and regulatory leverage was at 99.7%.
AI Disruption Monitoring: Monitoring AI's impact on portfolio companies, with many benefiting from AI adoption and innovation.
Capital Structure: Maintains a permanent capital structure with no redemption risk, enabling long-term strategy execution.
Leadership Expansion: Announced leadership changes to scale the platform, with Seth Meyer transitioning to President and Andrew Olson becoming CFO.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Volatility: The company faced significant market volatility in Q1 2026, driven by macroeconomic concerns such as the conflict in the Middle East and fears surrounding AI disruption. This volatility has led to increased focus on liquidity and redemption across the private credit space.
AI Disruption: AI disruption is expected to impact numerous industries, potentially altering business models, margin profiles, and operational efficiencies. While some companies in the portfolio are benefiting from AI adoption, others may face challenges, creating winners and losers over time.
Equity and Credit Market Pullback: A sharp pullback in certain parts of the equity and credit capital markets has created challenges for ongoing M&A discussions and valuation processes, particularly in the technology sector.
Regulatory and Market Yield Adjustments: The company experienced $31.1 million in net unrealized depreciation on debt investments, largely due to market yield adjustments associated with general market volatility.
Concentration in AI and Machine Learning: Venture capital investment activity in Q1 was heavily concentrated in AI and machine learning, which could pose risks if these sectors face downturns or fail to meet high expectations.
Increased Leverage: GAAP leverage increased to 115.4%, which is at the high end of the company's historical range. While this supports growth, it also increases financial risk.
Prepayment Activity: The company expects prepayments to increase materially in Q2, driven by M&A activity. While this provides liquidity, it also creates uncertainty in capital redeployment.
Unrealized Depreciation in Equity Positions: The company reported $12.3 million in net unrealized depreciation attributable to valuation movements in publicly and privately held equity positions, reflecting market volatility.
Technology Sector Challenges: The sharp pullback in equity valuations in certain technology sectors has slowed M&A discussions, creating uncertainty in exit valuations and process timing.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Market Volatility and Business Environment: The company expects continued higher-than-normal market and macro volatility in 2026, driven by AI disruption fears and geopolitical conflicts. This environment is anticipated to create a robust new business environment for Hercules.
Capital Deployment and Liquidity: Hercules plans to maintain a defensive balance sheet while enhancing liquidity as needed. The company expects to opportunistically deploy capital during market volatility to benefit shareholders and stakeholders in the long term.
Origination and Prepayment Guidance: The company expects originations to moderate in Q2 2026 and be more back-end weighted. Prepayments are projected to increase materially in Q2, ranging from $350 million to $500 million, driven largely by M&A activity.
Core Yield Projections: Core yield is expected to remain relatively flat in Q2 2026, in the range of 12% to 12.5%, given the Federal Reserve's steady interest rate policy.
AI Disruption and Market Impact: Hercules anticipates AI to disrupt numerous industries over the coming years, leading to changes in business models, margin profiles, and operational efficiencies. The company will continue to monitor and adapt to these changes.
M&A and Exit Activity: M&A exit activity is expected to accelerate in 2026, although with uncertainties regarding valuations and process timing. The company has observed positive signs with recent IPOs and acquisitions within its portfolio.
Portfolio Monitoring and Credit Quality: The company will maintain enhanced portfolio monitoring due to market volatility. Credit quality remains strong, with a diversified asset base and a focus on life sciences and technology sectors.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Base shareholder distribution coverage: Net investment income in Q1 comfortably covered the base shareholder distribution by 120%.
Supplemental distribution: This is the 23rd consecutive quarter of providing a supplemental distribution in addition to the regular quarterly base distribution.
Undistributed earnings spillover: Exited Q1 with undistributed earnings spillover of $149.1 million or $0.80 per ending shares outstanding.
Share repurchase or buyback program: No specific mention of a share repurchase or buyback program was made in the transcript.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Why is there a disconnect between the reality and fundamentals of the business relative to perceptions, and what are the biggest drivers of the portfolio's strong results?
A:Scott Bluestein explained that their underwriting approach in the venture and growth stage market is fundamentally different from traditional underwriting. They target metrics such as under 1x debt to ARR, sub 20% LTV, and debt to invested equity of less than 30%, providing significant equity cushion. The portfolio is highly diversified, with 50% in life sciences and a significant portion of technology investments outside software, which has helped maintain strong performance despite volatility.
Q:How should fee income and spreads on new deals in Q2 be considered, and how do they compare to investments tied to prepayments?
A:Seth Meyer stated that prepayments in Q2 are a positive indicator of portfolio quality, driven by known M&A events. This will lead to slightly higher fee income, but no specific guidance was provided. Spreads widened by 50-75 basis points during volatile periods but have since narrowed to about 25 basis points higher than at the start of the year. The focus remains on enhancing structure over incremental spread increases.
Q:What is the deployment backdrop for 2026, and has there been heightened deployment in any particular sector?
A:Scott Bluestein highlighted a focus on diversification between life sciences and technology. Q1 2026 saw record-breaking commitments of $1.8 billion, with additional commitments of $79 million closed and $506 million pending. The team remains disciplined in capital deployment and optimistic about 2026 opportunities.
Q:How is the company achieving M&A success in a slow M&A market?
A:Scott Bluestein credited the investment teams for identifying and underwriting deals with attractive M&A targets. Year-to-date, four companies announced M&A events, and several others are in active discussions. However, there is increased variability in timing and valuation.
Q:What is driving the decline in PIK income, and is the company deprioritizing PIK?
A:Seth Meyer explained that the decline in PIK income is due to prepayments of loans underwritten in 2024 and 2025, where accrued PIK is paid in cash. Additionally, the company is intentionally deprioritizing PIK on new investments.
Q:How will prepayments influence the portfolio, and is there a shift away from software?
A:Scott Bluestein stated that prepayments provide an opportunity to reposition the portfolio but do not indicate a shift away from software. The company will continue to pursue attractive software loans while redeploying capital into other technology sectors like space tech and defense tech.
Q:Are software deals still being done despite market volatility?
A:Scott Bluestein noted that while the volume of software deals is lower than in the past, high-quality opportunities still exist. The company has over $580 million in signed term sheets, indicating continued activity.
Q:How are venture capitalists approaching valuations and capital deployment in the current environment?
A:Scott Bluestein emphasized that the company prioritizes structure over pricing in new deals. Venture capitalists are likely focusing on balance sheet strength and disciplined capital deployment.
Q:What are the key developments in life sciences, and how is the company positioned?
A:Scott Bluestein mentioned that life sciences companies are strengthening their balance sheets due to FDA uncertainty. The company sees strong clinical results and drug approvals as positive indicators for the sector.
Q:How is the company structuring deals in light of AI-related changes?
A:Scott Bluestein declined to provide specific details but mentioned that the company has made changes to deal structuring, including duration, covenants, and overall terms, to address risks and opportunities.
Q:Is AI driving increased M&A activity?
A:Scott Bluestein stated that AI is not a significant driver of increased M&A activity, though some strategics may be trying to get ahead of the AI curve.
Q:Why is the company deemphasizing PIK on new investments?
A:Scott Bluestein explained that the company aims to keep PIK income below a self-imposed limit and prefers cash income. The current environment does not necessitate frequent use of PIK.
Q:Review of Unclear Management Responses
A:Management avoided providing specific guidance on fee income for Q2, citing the need for events to play out. Additionally, Scott Bluestein declined to share detailed information about changes in deal structuring related to AI, citing proprietary considerations.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI disruption
Middle East
PIK income
President
adoption
asset base
capital market
collection
company portfolio
component
concern
conflict Middle
cycle
deal value
differentiator
environment Hercules
expansion
experience
finance
investment credit
loan PIK
loan duration
market volatility
model
origination investment
pace change
part
payment
platform capability
point PIK
portfolio record
process
professional
pullback
record investment
record origination
redemption
reporting
respect valuation
underwriting
volatility date
HTGC Transcript
Hercules Capital, Inc. (HTGC) Q1 2026 Earnings Call Transcript
Positive5-5
The earnings call reflects a stable financial performance with efficient debt management and strong credit quality. The Q&A reveals a disciplined approach to underwriting and capital deployment, with optimism for 2026 opportunities. The company maintains a diversified portfolio and strategic M&A success, despite market volatility. The deprioritization of PIK and focus on cash income indicate prudent financial management. Overall, the positive outlook for 2026 and robust commitments support a positive stock price reaction.
Hercules Capital, Inc. (HTGC) Q4 2025 Earnings Call Transcript
Positive2-13
The earnings call summary and Q&A reveal strong origination and exit activities, robust liquidity, and a conservative balance sheet, indicating financial health. While there are concerns about AI disruption, the company is well-positioned with a strategic focus on high-quality credits and growth in private funds. The positive outlook on M&A and disciplined lending approach further support a positive sentiment. Despite some uncertainties, the overall sentiment leans positive, suggesting a likely stock price increase of 2% to 8% over the next two weeks.
Hercules Capital, Inc. (HTGC) Q3 2025 Earnings Call Transcript
Unknown10-31
The earnings call presents a mixed picture: strong credit quality, liquidity, and cautious market strategies are positives, but lack of clear guidance on dividends and blockchain impact tempers enthusiasm. The Q&A reveals management's conservative stance, with muted effects from rate cuts and no major changes in portfolio mix. Despite some optimism, the absence of specific guidance and the slow Q3 originations suggest a balanced outlook, leading to a neutral sentiment.
Hercules Capital, Inc. (HTGC) Q2 2025 Earnings Call Transcript
Positive7-31
The earnings call summary highlights strong financial performance with record revenue and fundings, increased NAV, and stable yields. The Q&A section reveals confidence in future funding levels and strategic positioning despite competitive pressures. The management's cautious approach to equity investments and positive outlook on U.S. investments further support a positive sentiment. Given the company's market cap and the absence of critical negative factors, a positive stock price movement of 2% to 8% is likely over the next two weeks.
HTGC Slides
HTGC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
